Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
cancer
eli lilly
pfizer
startups
abbvie
clinical trials
deals
drug prices
gene therapy
What
bio
5
×
roundup
drug
companies
alzheimer’s
price
prices
week
acquisitions
albert
annual
approval
arena’s
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
bounty
bourla
ceo
cig
comeback
communities
company
conference
convo
corner
crispr
deals
delivered
different
earlier
esmo
europe
expressing
fail
failures
future
Language
unknown
Current search:
medicare
×
bio
×
" cancer immunotherapy "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More